Figure 2From: Synthesis, identification and in vivo studies of tumor-targeting agent peptide doxorubicin (PDOX) to treat peritoneal carcinomatosis of gastric cancer with similar efficacy but reduced toxicity Structure identifications confirmed by H 1 -NMR (A) and C 13 -NMR (B). Back to article page